PUBLICATIONS · 32530769
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 Aug 1
- First author
- Rao S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2020 Nov 20;38(33):3973-3974. doi: 10.1200/JCO.20.02137.
- note
- Source null
- related pmid
- 33026940
- relationship
- Comment in
- citation
- J Clin Oncol. 2020 Nov 20;38(33):3974-3975. doi: 10.1200/JCO.20.02643.
- note
- Source null
- related pmid
- 33026941
- relationship
- Comment in
Authors and identifiers
- name
- Rao S
- type
- Author
- name
- Sclafani F
- type
- Author
- name
- Eng C
- type
- Author
- name
- Adams RA
- type
- Author
- name
- Guren MG
- type
- Author
- name
- Sebag-Montefiore D
- type
- Author
- name
- Benson A
- type
- Author
- name
- Bryant A
- type
- Author
- name
- Peckitt C
- type
- Author
- name
- Segelov E
- type
- Author
- name
- Roy A
- type
- Author
- name
- Seymour MT
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rao S
- type
- Author
- name
- Sclafani F
- type
- Author
- name
- Eng C
- type
- Author
- name
- Adams RA
- type
- Author
- name
- Guren MG
- type
- Author
- name
- Sebag-Montefiore D
- type
- Author
- name
- Benson A
- type
- Author
- name
- Bryant A
- type
- Author
- name
- Peckitt C
- type
- Author
- name
- Segelov E
- type
- Author
- name
- Roy A
- type
- Author
- name
- Seymour MT
- type
- Author
- bibliography ids
- nci-bib-b2a636e43d8e655b40c5f609
- book metadata
- content sha256
- 5f749f9e8c589f7f89417b5433f1e5ffa1bf0373fa4172c0d593191d89857f26
- document type
- citation
- dois
- 10.1200/JCO.19.03266
- electronic publication date
- display
- 2020 Jun 12
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32530769
- immutable id
- pubmed:32530769@5f749f9e8c589f7f89417b5433f1e5ffa1bf0373fa4172c0d593191d89857f26
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 22
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2510-2518
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2020 Nov 20;38(33):3973-3974. doi: 10.1200/JCO.20.02137.
- note
- Source null
- related pmid
- 33026940
- relationship
- Comment in
- citation
- J Clin Oncol. 2020 Nov 20;38(33):3974-3975. doi: 10.1200/JCO.20.02643.
- note
- Source null
- related pmid
- 33026941
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 32530769
- provenance
- batch id
- 40d9eae1f1d369f13109
- provider
- NCBI PubMed ESummary
- record sha256
- 255bafdf96ef4ca168d9e828f5d3c20f70efcdedac4c261323cd6bbf2e50d70b
- response sha256
- 03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
- retrieved at
- 2026-09-09T23:47:52.637547+00:00
- publication date
- display
- 2020 Aug 1
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Preserved source evidence · Not medical advice
Triangle